Summary: A recent study in Switzerland, known as the Weed Care study, is exploring the effects of legal cannabis access on user consumption and mental health. This randomized trial revealed that participants purchasing cannabis legally experienced a minor reduction in problematic use, particularly among those who also use other substances.
Crucially, there was no observed rise in mental health issues, such as depression or anxiety, among those with legal access compared to users relying on black market purchases. After a six-month period, the control group was also granted legal access, and findings suggest an overall improvement in mental wellbeing across all participants after two years.
Key Facts:
- Reduced Problematic Use: Access to legal cannabis resulted in a slight decline in problematic consumption, especially among polydrug users.
- Mental Health Maintained: There was no increase in symptoms of depression, anxiety, or other mental health issues with legal access.
- Improved Wellbeing: Two years into the study, participants with legal access reported better mental health.
Discussion: The legalization of cannabis has been a topic of ongoing debate in Switzerland and many other nations, driven by various hopes and fears. On one side, advocates aim to reduce the black market, ensure safer product accessibility, and promote lower-risk consumption, alongside improved access to counseling services.
Conversely, critics worry that legal sales may normalize cannabis use, potentially encouraging more people to consume it and leading to a rise in addiction and mental health issues.
The Weed Care study aims to clarify these conversations through scientific insights, having kicked off in January 2023. It is a collaborative effort between the Addiction Department of Basel-Stadt, the University of Basel, and other psychiatric institutions.
Study Design:
Over the initial six months, the study involved a direct comparison between two randomized groups. Approximately 370 participants were split equally: one half could purchase cannabis legally at nine participating pharmacies and received counseling. The other half continued sourcing cannabis from the black market. Participants periodically reported their consumption habits and mental states via questionnaires.
“We’ve never had a controlled, randomized study like this before,” emphasizes Dr. Lavinia Baltes-Flückiger, who is involved in the research. Previous findings were based only on observational data.
Findings:
The study, published in the journal Addiction, indicates a slight decrease in problematic cannabis use among those with legal access, which is especially noticeable in individuals who use other drugs as well. “We saw a significant drop in problematic use within this subgroup,” Baltes-Flückiger explains.
The study also alleviated concerns that legal access might worsen mental health symptoms tied to cannabis use. After six months, there were no significant differences in depression or anxiety levels between the two groups.
After this period, the control group was granted the same legal access to cannabis, ensuring that all participants were motivated from the beginning to take part in the study. Initial assessments two years in show a notable improvement in the mental states of around 300 participants. “Legal access reduces the burden on users,” states Professor Marc Walter from the University of Basel.
About This Research
This study aims to measure the impacts of health-focused cannabis access versus illegal market access on consumption and associated mental health outcomes. Conducted in Basel-Stadt, Switzerland, it involved 378 adult cannabis users who were randomized over a six-month period. Participants included those receiving regulated access in pharmacies and a control group sourcing cannabis from illegal markets.
The primary goal was to evaluate the severity of cannabis misuse, supplemented by secondary assessments of depressive, anxiety, and psychotic symptoms, as well as overall consumption amounts.
While ten participants were not followed up, primary analyses included those with complete data. The results indicated some difference in cannabis misuse severity between the two groups, particularly less misuse among those in the legal cannabis group who also used other drugs. No significant changes were noted in secondary outcomes.
Conclusion
The findings suggest that public health-oriented access to recreational cannabis may lower usage and related harms, particularly among those with poly-drug use patterns.
